Previous

2012.10.01. Innovimmune: Structuring Immunotherapies
Next

2012.06.13. Innovimmune awarded NIH NIAID SBIR $0.6 Million grant for the development of its oral NCE INV-88 Macrophage Migration Inhibitory Factor (MIF) inhibitors for Autoimmune Diseases